RE: Only Vlad9 Sep 2023 13:50
Stu
Thats not how the stockmarket works as far as I know. Yes competition is there but look at Google, microsoft and amazon in the cloud business. They are all validated in theri own merits. They all have their strengths and weaknesses yet are all valued extremely high. The same here. HEMO has the science and whether it is CBR, CART or CDX, it just needs a little kickstart. I guess we all invested too early in this hyped up stock but now is the the right time to get in. WHY?
Because as you state clearly, it is very likely we will get CART IND APPROVED. Yes it maybe now or in the next few months but it is highly. That would value the science at IND stage anywhere between £100m and £300m which is the same as equivalent CART companies so anywhere between 10p and 30p share price. That is when i believe a placing will come. WHY?
because once they are over $50m value, more institutions will come. Once they are proven by the FDA trust will be there. I will then be reducing my committment since Phase 1 will require money and has risk. I am hopeful that the price will be 10p - 30p so skim some profits and even if a placing comes, all good, they will easily raise the money and even if they dilute, many shareholders will still be happy. Those that are not will sell of and move on.
So STRANGELY WE AGREE. A placing is likely at sometime in 2024 and after the next RNS which could be CART or CBR but is likely to drive this well beyond 5p and into an IND APPROVED COMPANY.